Although there are many possible applications for noninvasive brain stimulation in neurological and neuropsychiatric diseases, there are still concerns about the use of transcranial direct current stimulation (tDCS) in patients with intracranial implants, such as deep brain stimulation (DBS) electrodes. 
However, due to the invasive nature of DBS, noninvasive brain stimulation techniques, such as tDCS, have been investigated in movement disorders, making it a therapeutic alternative in clinical settings. Deep brain stimulation, e.g. of the subthalamic nucleus (STN-DBS), may be effective in movement disorders 1, 2, 3 , such as in patients with primary dystonia manifestations [4] [5] [6] measured by the Burke-Fahn-Marsden Dystonia Rating Scale, and may improve their quality of life in terms of physical functioning, bodily pain, and mental health measured by the 36-Item Short-Form General Health Survey 4 . Improvement has been reported in patients with medically refractory isolated dystonia, even 12 and 36 months after STN-DB surgery 5 . Similar effective results with bilateral STN-DBS for the treatment of movement disorders 6, 7 have suggested that bilateral STN-DBS may also be an interesting treatment option for cervical and generalized dystonia, improving dystonia symptoms, and improving mental health, even in patients who have already undergone bilateral pallidotomy 8 . Dystonia is a movement disorder in which sustained muscle contractions give rise to abnormal postures or involuntary movements 9, 10 . Evidence indicates that psychiatric morbidity is higher in patients with dystonia than in patients with other chronic diseases 11 , and depression, anxiety and obsessive-compulsive disorder are the most common psychiatric diagnoses in dystonia patients, with moderate to severe depression experienced by about a quarter of the patients with dystonia 12 . In the past, a few studies have drawn attention to a worrisome side effect, namely the worsening of mood and development of transient depression after DBS surgery 4 in patients with Parkinson' s disease 13 . However, a direct relationship with DBS has never been established 14, 15 . A noninvasive neuromodulatory tool, such as tDCS, could be a potential add-on therapy to enhance the effects of DBS. However, there is still no consensus on the most appropriate tDCS treatment protocols for most movement disorder patients. In addition, the presence of DBS electrodes is generally regarded as a contraindication to tDCS. Exclusion of patients with preexisting implants, especially intracranial implants, is common in tDCS trials, as a precautionary measure 16 . However, to the best of our knowledge, to date there has been no reported evidence of injury to a patient with an intracranial implant and no theoretical risk of injury based on computerized modeling.
We aimed to explore the safety of add-on tDCS in a 45-year-old female patient already undergoing STN-DBS for generalized dystonia, which was maximal in the neck and trunk, with relative limb sparing. Walking was possible, but neck dystonia forced her to turn her head upward and to the left, making it difficult to look straight ahead. Speech was also extremely forceful. She also presented with chronic neck and shoulder pain and mild depression. With DBS, there was partial but clinically-significant improvement, especially in neck dystonia and speech, and botulinum toxin injections significantly reduced pain. However, depressive symptoms and anxiety were worse after the DBS surgery, probably because of high expectations by the patient and postoperative persistence of a few dystonic symptoms (although there was objective improvement).
METHODS
In an attempt to further alleviate the patient' s dystonic movements, compassionate use of tDCS was prescribed. A commercially available transcranial direct current stimulator (TransCranial ® , Hong Kong, China) was used to deliver 2.0 mA for 30 minutes per session through saline-soaked sponge electrodes (surface 35 cm²). Electrode placement on the scalp was determined using the International 10-20 EEG system.
Anodal cerebellar tDCS at 2 mA was initiated, targeting both hemispheres in each daily 30 minute session: 15 minutes of left cerebellar stimulation (O1-FC4) followed by 15 minutes of right cerebellar stimulation (O2-FC3), from Monday to Friday for three weeks (15 sessions). Care was taken to keep the electrodes and wires away from surgical skull defects and DBS leads. The location and polarity of the electrodes, number of sessions, and current intensity were chosen on the basis of previously-reported results demonstrating that 2 mA of anodal tDCS over the cerebellum for 15-20 minutes is capable of improving certain movement disorders 17 , such as Parkinson's disease, by improving the levodopa-induced dyskinesias 18, 19 , cervical dystonia 20, 21 , and other neurological disorders including cerebellar ataxia 22, 23, 24, 25 . Informed consent was obtained from the patient prior to all procedures. The patient was evaluated by a neurologist (NA) and a neuropsychologist (AI) during the entire tDCS treatment.
RESULTS
After STN-DBS surgery, the patient reported substantial improvement one month after the surgery, compared with her previous condition. The most striking changes were in neck dystonia and speech. However, the patient also reported worsening depression and anxiety, which increased even two to three years after DBS surgery. Although our main goal was to further improve dystonic movements, after 10 tDCS sessions there was also improvement in mood according to the Beck Depression Inventory: the patient's score changed from 14 (mild mood disturbance) to 4 (normal score). There was also further improvement in generalized dystonia (which lasted for over 12 hours after each session), chronic pain and cognitive functions (executive function and attention), as evaluated by a neurologist specialized in movement disorders (NA) and a neuropsychologist (AI), who evaluated the patient and recorded videos before and after tDCS sessions to document any effects upon dystonia. The Table summarizes these findings. In spite of the presence of DBS electrodes, the tDCS application was uneventful. There were no post-session headaches, skin redness or electrolytic burns, or signs of autonomic dysfunction (blood pressure and heart rate did not change during tDCS sessions, and there were no syncope episodes, pallor or excessive sweating). Moreover, executive function and attention were not adversely affected; on the contrary, they improved after tDCS sessions. Therefore, our case study demonstrated that frontocerebellar tDCS may be performed safely, even in the presence of DBS electrodes.
DISCUSSION
The main conclusion to be drawn from this case study is that tDCS may be safely performed in patients with implanted deep brain stimulation electrodes, in spite of the traditional recommendation that such patients be excluded from clinical tDCS trials.
The mechanism of action of tDCS is such that no direct neuronal depolarization occurs 26 ; currents that actually reach the brain are attenuated by scalp and skull resistance. This is in sharp contrast to what happens in the case of transcranial magnetic stimulation, which employs a strong magnetic field and is capable of inducing intracranial currents of enough magnitude to cause neuronal firing of action potentials 27, 28 . While transcranial magnetic stimulation should be avoided in patients with intracranial metallic implants (including DBS electrodes) due to the danger of electromagnetically-induced undesirable currents, tDCS should be safe, as long as the stimulation electrodes are kept away from the DBS leads or skull burr-holes, as in the present case.
Table. Transcranial direct current stimulation (tDCS) effects on different neuropsychological and neuropsychiatric parameters in a dystonia patient before and after 10 tDCS sessions.
Instruments and measures Before tDCS After tDCS
Neuropsychiatric symptoms and psychopathology Beck Depression Inventory, n/11 14 4 Beck Anxiety Inventory, n/11 21 1
Activities of Daily Living
Pfeffer's functional assessment questionnaire , n/8 2 0
Barthel index, n ≤ 91 95 100
Global cognition score
Mini-mental state examination, n/26 29 30 Executive and attention functions Digit span forward (Wechsler adult intelligence scale), n/16 7 7
Digit span backward (Wechsler adult intelligence scale), n/14 4 6
Digit span (forward -backward), n/4 3 1
Digit span (forward + backward), n/30 11 13
Stroop color-word test Victoria Esmaeilpour et al. 29 have recently measured currents in DBS electrodes in the subthalamic nucleus and nucleus accumbens in patient volunteers after brief tDCS applied to O2 (international 10-20 system) with a supraorbital reference. They also measured currents in implanted electrodes in the motor cortex. Their results showed that voltages produced by tDCS electrodes were smaller in DBS electrodes in comparison with the cortical target. There were no untoward effects, but their tDCS stimulation was very brief (30 seconds), while our patient underwent 20 minute-sessions.
Our patient also showed normalization of her depression scores. A recent study by Deng et al. 4 has shown that STN-DBS is effective and very safe in generalized dystonia; in their series, only 2/14 patients experienced depression after surgery, and then only transiently. Therefore, it is unlikely that our patient's long-standing mild depression was related to DBS. But how does one explain mood improvement after cerebellar tDCS? A recent literature review cites evidence of the physiological role of the cerebellum in maintaining mood as well as its implication in the pathophysiology of bipolar disorder and major depressive disorder. Minichino et al. 30 suggested the cerebellum has roles in cognition, mood and behavior 31, 32, 33 . In their study, they pointed to the role of the cerebellum in modulating emotional processing, providing strong evidence from clinical and electrophysiological studies to support their view. They concluded that the cerebellum seems to be a sort of emotional "pacemaker. "
As to the effect of cerebellar tDCS, another recent study by Newstead et al. 34 found that frontocerebellar tDCS was able to improve mood, even in non-depressed participants, both acutely and after repeated sessions. However, the effect observed in this case study, although interesting, might have been due to a placebo effect and needs to be further examined in future studies for a better understanding of its consistency and potential mechanisms.
These findings indicate a potential application for tDCS as a safe and effective add-on neuromodulatory tool after DBS treatment of patients with movement disorders, such as generalized dystonia.
